INOVIQ Ltd
ASX: IIQ.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Leearne Maree Hinch
- Employees
- 15
- Headquarters
- Notting Hill, Australia
- IPO year
- 1988
- Market cap
- A$38.5M
- Website
- https://www.inoviq.com
Loading IIQ…
Loading profile data…Frequently asked questions about IIQ
What does INOVIQ Ltd (IIQ.AX) do?
INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO...
Where does IIQ.AX trade?
INOVIQ Ltd (IIQ.AX) trades on the Australian Securities Exchange.
What sector is IIQ.AX in?
INOVIQ Ltd (IIQ.AX) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of INOVIQ Ltd?
Leearne Maree Hinch is the chief executive officer of INOVIQ Ltd (IIQ.AX).
Where is INOVIQ Ltd headquartered?
INOVIQ Ltd is headquartered in Australia.
Does IIQ.AX pay a dividend?
INOVIQ Ltd (IIQ.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IIQ.AX go public?
INOVIQ Ltd (IIQ.AX) completed its initial public offering in 1988.